Sistemic Ltd. Company Profile
Sistemic’s primary business is focused on providing innovative microRNA-based problem-solving services and kit-based products to areas of unmet need within Pharmaceutical, Biotechnology and the Cell Therapy research, development and manufacture markets. MicroRNAs are seen as the master controllers of a cell and as such Sistemic believe that they are providing instructive information on effects on a whole cell or organism rather than an isolated pathway. This system approach means that the data produced is more indicative of the biology and more diagnostic of actual effect. Their extensive suite of tools for the Cell Therapy community includes SistemQC™ which is used to characterise cells including stem cells (Cell Identity, Purity, Potency, and Safety) as well as monitoring the QC of production. In addition, the drug development markets are served through a range of products which include SistemTOX™, SistemKB™ and SistemRNA™.
News Articles
Merck Millipore and Sistemic to use miRNA for cell culture QC
Merck Millipore and microRNA detection firm Sistemic have teamed up to develop QC kits for stem cell production.Â
PCT to test Sistemic's microRNA tech for cell therapy production
Progenitor Cell Therapy (PCT) has started testing to see if an RNA-based characterization tech developed by Sistemic can improve cell therapy production.
Sistemic, PCT collaborate to study SistemQC stem cell characterization technology
Sistemic, a UK-based miRNA profiling company, has signed a deal with NeoStem subsidiary Progenitor Cell Therapy (PCT) to start evaluation studies on Sistemic’s SistemQC stem cell characterization te...
Sistemic strengthens understanding of Next-Generation Cell Therapies with CYTX
 Sistemic has formed a customer relationship with Cytori Therapeutics (CYTX), to utilize their proprietary SistemQC technology platform in its US cardiac cell therapy clinical trial to molecularly ch...
Sistemic Ltd announces Companion Biomarker Program
29 June 2011: Sistemic, UK: Sistemic, a global company with expertise in microRNA , has announced the release of it’s new Companion Biomarker program. Extending the company’s ex...
Sistemic supports Talent Scotland
21 September: Sistemic, UK: Sistemic, a growing and successful biotechnology company, recently recruited a new Senior Bioinformatician with Talent Scotland’s help. Sistemic and Talent Scotland...
29 November: Sistemic, UK: Dr Verna McErlane, Director of Commercial Operations, International at Sistemic, is scheduled to give her own special insight into advanced analytical models to support...
Drugs and Medications
None
PubMed Articles
Syzygium cumini (L.) Skeels (Sc) belongs to the medicinal plants with an important source of phenolic compounds. Sc has been shown to possess antioxidant and anti-inflammatory properties. Methylmercur...
Clinical Trials
VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy
The primary objective of this study is to assess the antitumor activity (in terms of overall response rate - ORR - i.e. sum of complete and partial responses)of bortezomib in pretreated MA...
Companies
Sistemic’s primary business is focused on providing innovative microRNA-based problem-solving services and kit-based products to areas of unmet need within Pharmaceutical, Bi...
Sistemic is focused on providing innovative microRNA-based problem-solving services to areas of unmet need within Pharmaceutical and Biotechnology R&D and manufacturing. MicroRNAs are perceived...
More Information about "Sistemic Ltd." on BioPortfolio
We have published hundreds of Sistemic Ltd. news stories on BioPortfolio along with dozens of Sistemic Ltd. Clinical Trials and PubMed Articles about Sistemic Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sistemic Ltd. Companies in our database. You can also find out about relevant Sistemic Ltd. Drugs and Medications on this site too.
